Find out the latest news from international oncology congresses and stay at the forefront of clinical innovation and advances in lung cancer research. Each SPECIAL ISSUE – CONGRESS REPORT features informative summaries of key topics from lung cancer to come out of a major international oncology congress.
The memo inOncology Medical education series: keeping oncologists at the forefront of lung cancer research. memo – inOncology Special Issue Preceptorship reports summarise the latest in lung cancer research and treatments to come out of our sponsored Preceptorship meeting series. The Fundamentals of Designing Clinical Trials series arms oncologists with the information they need to plan and conduct an oncology trial.
News
Springer is delighted to announce a new memo inOncology SPECIAL ISSUE congress report in collaboration with CSCO!
Congress Report CSCO 2017 annual meeting
The 20th Chinese Society of Clinical Oncology (CSCO) annual meeting took place in Xiamen from September 26th to 30th, 2017. Highlights include the latest CSCO guidelines for NSCLC, how best to diagnose and treat EGFR-mutated NSCLC, how best to treat lung cancer patients with brain metastases, treatment options for lung squamous cell carcinoma, and the response to immunotherapy.
Preceptorship Singapore – BASICS OF LEADERSHIP IN CLINICAL RESEARCH WITH A FOCUS ON LUNG CANCER
Springer and The Japanese Society of Medical Oncology (JSMO) held the Young Oncologist Preceptorship over the 8th–10th December 2017, in Singapore, bringing young oncologists under the guidance of a panel of renowned experts in the field of lung cancer…Access the report here
Expert interviews at WCLC
IASLC 18th WCLC 2017, Yokohama
Prof. David Gandara discusses the latest progress in EGFR, ALK, and checkpoint inhibitor therapies for NSCLC.
IASLC 18th WCLC 2017, Yokohama
Prof. Keunchil Park discusses how lung cancer treatments have developed since the advent of chemotherapy, and how best to deliver optimal care to lung cancer patients worldwide, and specifically in South Korea and Japan.
IASLC 18th WCLC 2017, Yokohama
Prof. Ramaswamy Govindan discusses the importance of chemotherapy in today’s treatment landscape, and the importance of ethnic genomic differences in mutation rates in lung cancer.
IASLC 18th WCLC 2017, Yokohama
Prof. Paul A. Bunn discusses current and future treatment options in lung cancer.